Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
The researchers’ goal was to provide an overview of endpoints and outcomes in the current acute migraine clinical trial literature to facilitate the development of novel treatments.
A team of investigators sought to assess the prevalence of pre-existing sleep disorders and their relationship to disease outcomes in patients with severe COVID-19.
Researchers systematically reviewed literature to understand the performance and sensitivity of alternative sample types compared with that of nasopharyngeal swabs for the diagnosis of SARS-CoV-2.
Walgreens was not following U.S. government guidance on when to give second doses of COVID-19 vaccines but will start doing so after hearing from the CDC.
With cannabis in the United States becoming more widely available for medical and recreational use, some with Parkinson disease (PD) are trying cannabis to control symptoms. However, not that much is currently known about the attitudes and experiences regarding cannabis use among those with PD.
The researchers reviewed studies evaluating the effectiveness of minocycline in alleviating neuropathic pain because it reduces microglial activation, which suggests that it may reduce neuropathic pain.
Those previously infected with SARS-CoV-2 have antibody responses to one dose of the BNT162b2 mRNA vaccine comparable to individuals receiving two dose.
The objective of this study was to assess the implementation of teleneurology, including patient and clinician experiences, during the COVID-19 pandemic.
The researchers investigated how low levels of B vitamins were associated with peripheral neuropathy and the effect of vitamin treatment on symptoms of pain.
